Question 1

What is Evkeeza?

Accepted Answer

Evkeeza is a monoclonal antibody that functions as an angiopoietin-like 3 (ANGPTL3) inhibitor. It is used to lower high levels of low-density lipoprotein (LDL) cholesterol, which is commonly known as bad cholesterol.

The medication works by blocking a specific protein that normally interferes with the breakdown of fats in the body. By inhibiting this protein, the drug helps the body more effectively clear cholesterol from the bloodstream.

Question 2

What is Evkeeza used for?

Accepted Answer

Evkeeza is used to treat homozygous familial hypercholesterolemia .

Question 3

How does Evkeeza work?

Accepted Answer

How Evkeeza Lowers Cholesterol

Evkeeza belongs to a class of medications called angiopoietin-like 3 (ANGPTL3) inhibitors. It is a monoclonal antibody, which is a type of protein designed to recognize and bind to a specific structure in the body.

The Role of ANGPTL3

In the body, the ANGPTL3 protein acts as a regulator for how fats are processed. It normally works by slowing down or inhibiting certain enzymes that are responsible for breaking down fats and clearing cholesterol from the bloodstream. When this protein is active, it can lead to higher levels of cholesterol circulating in the blood.

Mechanism of Action

Evkeeza works by binding to and blocking the ANGPTL3 protein. By neutralizing this protein, the medication allows the body's fat-clearing enzymes to work more effectively. This process helps the body to:

Increase the breakdown of fats in the blood.

Lower levels of low-density lipoprotein (LDL) cholesterol, commonly known as bad cholesterol.

Reduce levels of other lipids, including triglycerides and high-density lipoprotein (HDL) cholesterol.

Why It Is Unique

Most traditional cholesterol-lowering medications, such as statins, work by helping the liver remove cholesterol through specific pathways called LDL receptors. However, some people with a rare genetic condition called homozygous familial hypercholesterolemia (HoFH) have very few or no functioning LDL receptors, making standard treatments less effective. Because Evkeeza works through a different pathway that does not rely on these receptors, it provides a way to lower cholesterol for patients who have limited treatment options.

Question 4

What are the active ingredients in Evkeeza?

Accepted Answer

The active ingredient in Evkeeza is evinacumab .

Question 5

What are the side effects of Evkeeza?

Accepted Answer

Common side effects of Evkeeza may include:

nasopharyngitis

flu-like symptoms

dizziness

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Evkeeza?

Accepted Answer

Evkeeza belongs to the PCSK9 inhibitor drug class.

Question 7

What is the dosage of Evkeeza and how do I take it?

Accepted Answer

Administration

Evkeeza is given as an infusion into a vein (intravenous or IV). This procedure is performed by a healthcare professional in a medical setting, such as a doctor's office, clinic, or hospital. The infusion process typically takes about one hour to complete.

Frequency

This medication is usually scheduled once every four weeks. It is important to keep all appointments for your infusions to ensure the medication works effectively.

Missed Doses

If you miss an appointment for an infusion, contact your healthcare provider as soon as possible to reschedule. Once you receive the missed dose, your next dose will typically be scheduled four weeks from that date.

Question 8

Is Evkeeza safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Based on findings from animal studies, Evkeeza may cause harm to a developing fetus. There is limited data regarding the use of this medication in pregnant women. Healthcare providers typically recommend that pregnancy be avoided during treatment.

For individuals who can become pregnant:

A pregnancy test may be required before starting treatment to ensure you are not pregnant.

Effective birth control should be used during treatment and for at least 5 months after the final dose.

If you become pregnant while receiving this medication, you should notify your healthcare provider immediately.

Breastfeeding

It is currently unknown whether Evkeeza passes into human breast milk, how it affects a nursing infant, or if it impacts milk production. Because many drugs are excreted in human milk and there is a potential for serious adverse reactions in the infant, the decision to breastfeed while using this medication should be discussed with a healthcare professional to weigh the potential risks and benefits.

Question 9

What forms and strengths does Evkeeza come in?

Accepted Answer

Evkeeza is supplied in the following form:

Intravenous Injection: A clear to slightly yellow, preservative-free solution provided in single-dose vials.

This medication is administered as an intravenous infusion, which means it is delivered directly into a vein by a healthcare provider.

Question 10

What is the FDA approval status of Evkeeza?

Accepted Answer

FDA Approval History

The U.S. Food and Drug Administration (FDA) approved Evkeeza in February 2021. It was the first FDA-approved treatment that binds to and blocks the function of angiopoietin-like 3 (ANGPTL3), a protein that plays a role in lipid metabolism.

Approved Indications

Evkeeza is indicated as an adjunct to other low-density lipoprotein cholesterol (LDL-C) lowering therapies for the treatment of adult and pediatric patients, aged 5 years and older, with homozygous familial hypercholesterolemia (HoFH).

HoFH is a rare, life-threatening genetic condition characterized by extremely high levels of LDL cholesterol.

The safety and effectiveness of Evkeeza have not been established in patients with other causes of high cholesterol, including heterozygous familial hypercholesterolemia (HeFH).

Regulatory Requirements and Safety Programs

There are currently no boxed warnings or Risk Evaluation and Mitigation Strategies (REMS) required by the FDA for this medication. However, it is a prescription-only drug that must be administered by a healthcare professional via intravenous infusion.

Question 11

What should I know about Evkeeza and cost?

Accepted Answer

Specific pricing information for Evkeeza is not detailed in the provided clinical sources. However, several factors related to its administration and medical use contribute to the overall cost of treatment.

Clinical Administration Costs

Evkeeza is administered as an intravenous (IV) infusion by a healthcare professional in a medical facility, such as a doctor's office or infusion center. Because it is not a self-administered medication, the total cost typically includes more than just the drug itself. Expenses may include:

The cost of the medication.

Facility fees for the use of the infusion center or clinic.

Professional fees for the healthcare staff who prepare and monitor the infusion.

Insurance and Authorization

Coverage for Evkeeza depends on the patient's specific health insurance provider and plan. Because it is a specialized therapy for a genetic form of high cholesterol, insurance companies often require prior authorization. This is a process where the healthcare provider must submit documentation to the insurer to confirm the medication is medically necessary before the cost is covered. Patients may be responsible for out-of-pocket expenses such as deductibles, copayments, or coinsurance as determined by their insurance policy.

Patients are encouraged to consult with their healthcare team and insurance provider to understand the specific financial requirements and coverage options available for their treatment plan.

Evkeeza

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Price Information

FAQ

Found an Error?